ARTICLE | Financial News
Supernus raises $350M in convertible senior notes
March 16, 2018 7:32 PM UTC
Neurology company Supernus Pharmaceuticals Inc. (NASDAQ:SUPN) raised $350 million on March 15 through the sale of 0.625% convertible senior notes due 2023. The notes have an initial conversion price ...
BCIQ Company Profiles